Evidence map›Paper›PMID 39240167›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

Ebi3 Binding to IFN-γ and IL-10 Limits Their Function.

Ellen N Scott, Cheng Ye, Hiroshi Yano, Zhanna Lipatova, Erin Brunazzi, Kate M Vignali, Creg J Workman, Dario A A Vignali

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ellen N ScottDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Cheng YeDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Hiroshi YanoDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.ORCID 0000-0002-3098-2629
Zhanna LipatovaDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Erin BrunazziDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Kate M VignaliDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Creg J WorkmanDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.ORCID 0000-0002-9964-9509
Dario A A VignaliDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.ORCID 0000-0002-2771-5992

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
Training in Cellular & Molecular Mechanisms of Tumor RejectionT32CA082084 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Robert J Binder, Dario AA Vignali · 1999 to 2026
$9.2M
Regulatory T cells and the tumor microenvironmentR35CA263850 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Dario AA Vignali · 2021 to 2026
$5.4M
A Regulatory Triad: IL35, Tregs and iTr35R01AI091977 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VIGNALI, DARIO AA · 2011 to 2015
$2.0M
NCI NIH HHS P30 CA047904NCI NIH HHS R35 CA263850NCI NIH HHS T32 CA082084NIAID NIH HHS R01 AI091977
6 · The paper itself

Abstract

EBV-induced gene 3 (Ebi3) is a β subunit within the IL-12 cytokine family that canonically binds to α subunits p19, p28, or p35 to form the heterodimeric cytokines IL-39, IL-27, and IL-35, respectively. In the last decade, the binding partners for Ebi3 have continued to expand to include IL-6 and the other IL-12 family β subunit p40, revealing the possibility that Ebi3 may be able to bind to other cytokines and have distinct functions. We first explored this possibility utilizing an in vivo mouse model of regulatory T cell-restricted deletions of the subunits composing the cytokine IL-35, p35, and Ebi3, and we observed a differential impact on CD8+ T cell inhibitory receptor expression despite comparable reduction in tumor growth. We then screened the ability of Ebi3 to bind to different cytokines with varying structural resemblance to the IL-12 family α subunits. These in vitro screens revealed extracellular binding of Ebi3 to both IFN-γ and IL-10. Ebi3 bound to IFN-γ and IL-10 abrogated signal transduction and downstream functions of both cytokines. Lastly, we validated that extracellular complex formation after mixing native proteins resulted in loss of function. These data suggest that secreted partnerless Ebi3 may bind to cytokines within the extracellular microenvironment and act as a cytokine sink, further expanding the potential immunological impact of Ebi3.

Indexed as

Interferon-gammaInterleukin-10Minor Histocompatibility AntigensAnimalsCD8-Positive T-LymphocytesHumansInterleukinsMiceMice, Inbred C57BLMice, KnockoutProtein BindingReceptors, CytokineSignal TransductionT-Lymphocytes, RegulatoryEbi3 protein, mouseIL10 protein, mouseInterferon-gammaInterleukin-10InterleukinsMinor Histocompatibility AntigensReceptors, Cytokine

Identifiers

PMID39240167
PMCPMC11458358

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.